Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Limes Schlosskliniken AGFRA:LIK -0.94%32 Return-on-Tangible-Equity is 29.65% as of Dec. 2025, which is 31% below its 10-year median of 43.16. GuruFocus rates FRA:LIK with a GF Score™ of 32/100 and a GF Value™ of €499.57. The stock has 4 warning signs investors should review. Among 580 Healthcare Providers & Services companies, Limes Schlosskliniken AG ranks better than 80.52% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Limes Schlosskliniken AG's annualized net income for the quarter that ended in Dec. 2025 was €4.76 Mil. Limes Schlosskliniken AG's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €16.07 Mil. Therefore, Limes Schlosskliniken AG's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 29.65%.
The historical rank and industry rank for Limes Schlosskliniken AG's Return-on-Tangible-Equity or its related term are showing as below:
FRA:LIK'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 40.96 Med: 43.16 Max: 91.27
Current: 40.96
During the past 9 years, Limes Schlosskliniken AG's highest Return-on-Tangible-Equity was 91.27%. The lowest was 40.96%. And the median was 43.16%.
FRA:LIK's Return-on-Tangible-Equity is ranked better than 80.52% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs FRA:LIK: 40.96
Limes Schlosskliniken AG (FRA:LIK) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Limes Schlosskliniken AG Return-on-Tangible-Equity Related Terms
Limes Schlosskliniken AG Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Limes Schlosskliniken AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Limes Schlosskliniken AG Return-on-Tangible-Equity Chart
FRA:LIK vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Limes Schlosskliniken AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Limes Schlosskliniken AG Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Limes Schlosskliniken AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Limes Schlosskliniken AG's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 29.65% mean?
Limes Schlosskliniken AG (FRA:LIK) has a Return-on-Tangible-Equity of 29.65% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Limes Schlosskliniken AG and its competitors. This is 31% below median its historical median of 43.16. Over the past decade, Limes Schlosskliniken AG's Return-on-Tangible-Equity has ranged from 40.96 to 91.27. According to the industry distribution chart, Limes Schlosskliniken AG ranks #113 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 19.5%.
Is Limes Schlosskliniken AG's Return-on-Tangible-Equity too high?
Limes Schlosskliniken AG's current Return-on-Tangible-Equity of 29.65% is 31% below median its 10-year median of 43.16. Over the past 10 years, this metric has ranged from a low of 40.96 to a high of 91.27. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. Limes Schlosskliniken AG's value of 29.65% is 194% above this industry median. Based on the distribution chart, Limes Schlosskliniken AG ranks #113 out of 580 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Limes Schlosskliniken AG has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Limes Schlosskliniken AG's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Limes Schlosskliniken AG ranks #113 out of 580 companies for Return-on-Tangible-Equity. This places Limes Schlosskliniken AG in the top 20% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.09. Limes Schlosskliniken AG's value of 29.65% is 194% above this benchmark. Historically, Limes Schlosskliniken AG's own Return-on-Tangible-Equity has ranged from 40.96 to 91.27 over the past decade. While the company's 10-year median is 43.16 vs. the industry median of 10.09, Limes Schlosskliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Limes Schlosskliniken AG's current Return-on-Tangible-Equity of 29.65% is 194% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Limes Schlosskliniken AG and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Limes Schlosskliniken AG's current Return-on-Tangible-Equity is 29.65%, which is 31% below median its own 10-year median of 43.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Limes Schlosskliniken AG stock overvalued right now?
Limes Schlosskliniken AG (FRA:LIK) has a current Return-on-Tangible-Equity of 29.65%. The stock's GF Value™ is €499.57, compared to a current price of €525.00 — trading 5.1% above its estimated fair value. The current Return-on-Tangible-Equity is 29.65%, which is 31% below median its 10-year median of 43.16 and 194% above the Healthcare Providers & Services industry median of 10.09. Limes Schlosskliniken AG's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Limes Schlosskliniken AG (FRA:LIK), the current Return-on-Tangible-Equity is 29.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Limes Schlosskliniken AG (FRA:LIK) Overvalued in 2026?
Based on GuruFocus' analysis, Limes Schlosskliniken AG stock appears to be overvalued.
The current stock price of €525.00 is trading 5.1% above its estimated GF Value™ of €499.57.
Key valuation signals for FRA:LIK:
Return-on-Tangible-Equity: 29.65% (31% below median its 10-year median of 43.16)
GF Value™: €499.57 vs. price of €525.00 (5.1% above fair value)
Industry Position: 194% above the Healthcare Providers & Services median (#113 of 580)
No single metric tells the full story. See the FRA:LIK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.
32GF Score
Get the complete analysis for FRA:LIK
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LIK has been successfully added to your 
